SELDI‐TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions

Proteomic profiling with SELDI‐TOF MS has facilitated the discovery of disease‐specific protein profiles. However, multicenter studies are often hindered by the logistics required for prompt deep‐freezing of samples in liquid nitrogen or dry ice within the clinic setting prior to shipping. We report high concordance between MS profiles within sets of quadruplicate split urine and serum samples deep‐frozen at 0, 2, 6, and 24 h after sample collection. Gage R&R results confirm that deep‐freezing times are not a statistically significant source of SELDI‐TOF MS variability for either blood or urine.

[1]  M. Kretzler,et al.  Bioinformatic analysis of the urine proteome of acute allograft rejection. , 2004, Journal of the American Society of Nephrology : JASN.

[2]  Emanuel F Petricoin,et al.  Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. , 2004, The Journal of urology.

[3]  Lisa H. Cazares,et al.  Surfaced-Enhanced Laser Desorption/Ionization Time-of-Flight (SELDI-TOF) Differentiation of Serum Protein Profiles of BRCA-1 and Sporadic Breast Cancer , 2004, Annals of Surgical Oncology.

[4]  S. Mok,et al.  Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix. , 2004, Cancer letters.

[5]  P. Lewczuk,et al.  Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease , 2004, Biological Psychiatry.

[6]  S. Ramaswamy,et al.  Microarrays for an integrative genomics , 2004 .

[7]  T. Kang,et al.  Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons , 2003, Proteomics.

[8]  J. Potter,et al.  A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. , 2003, Biostatistics.

[9]  D. Chan,et al.  Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis , 2003, Annals of surgery.

[10]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[11]  H. Otu,et al.  Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling , 2005, Clinical chemistry and laboratory medicine.

[12]  P. Nickerson,et al.  Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. , 2004, Kidney international.

[13]  P. Nickerson,et al.  Proteomic-based detection of urine proteins associated with acute renal allograft rejection. , 2004, Journal of the American Society of Nephrology : JASN.